Hourigan, C. S., Beugelink, L., Othman, J., Gui, G., Ivey, A., Dillon, R., Thiede, C., Levis, M. J., Dillon, L. W., Wei, A. H., Tiong, I. S., Loo, S., Döhner, K., Arnhardt, I., Kowalik, A., Potter, N., Kim, D. D. H., Preudhomme, C., Duployez, N., Heuser, M., Valk, P. J. M. (2026). ELN-DAVID recommendations for NGS-based
                    <i>FLT3</i>
                    -ITD MRD testing for patients with acute myeloid leukemia. Blood. https://doi.org/10.1182/blood.2026033569